Portugal - Lipid Modifying Medicine Use
Since 2014, Portugal Lipid Modifying Medicine Use increased 2.3% year on year. In 2019, the country was ranked number 15 among other countries in Lipid Modifying Medicine Use with 117.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Portugal is overtaken by Israel, which was number 14 with 118.2 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Hungary with 112.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Denmark lead the ranking with 159.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, an increase of 3.5% versus 2018. United Kingdom, Belgium and Norway respectively ranked number 2, 3 and 4 in this ranking. Lithuania recorded the best 5 years average growth at +15% per year, while Slovakia witnessed the worst performance at -7% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 117.80 |
| 2018 | 114.40 |
| 2017 | 110.30 |
| 2016 | 110.70 |
| 2015 | 107.00 |
How does Portugal rank in Lipid Modifying Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Denmark
|
160 | 2019 | +3.5 % | +3.8 % | View data | |
| 2 |
#2
United Kingdom
|
153 | 2019 | +1.7 % | +2.3 % | View data | |
| 14 |
#14
Israel
|
118 | 2019 | +2.8 % | +1.6 % | View data | |
| 15 |
#15
Portugal
|
118 | 2019 | +3.0 % | +2.3 % | View data | |
| 16 |
#16
Hungary
|
113 | 2019 | +2.4 % | +1.6 % | View data | |